TrademarkDir
REZIPRES
LIVE

Serial Number

90060774

Owner

Eton Pharmaceuticals, Inc.

First Use Date

Mar 14, 2022

Filing Date

Jul 19, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

REZIPRES Trademark

Serial Number: 90060774 • Registration: 7043502

REZIPRES is a trademark filed by Eton Pharmaceuticals, Inc. on July 19, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Eton Pharmaceuticals, Inc. (2 trademarks)

21925 Field Parkway, Suite 235
Deer Park, IL 60010

Entity Type: 03

Dr. Reddy's Laboratories S.A.

Elisabethenanlage 11
Basel 4051 , CH

Entity Type: 11

Trademark Details

Filing Date

July 19, 2020

Registration Date

May 2, 2023

First Use Anywhere

March 14, 2022

First Use in Commerce

March 14, 2022

Published for Opposition

November 17, 2020

Goods & Services

Pharmaceutical preparations for treatment of hypotension; pharmaceutical compositions for treatment of hypotension; pharmaceutical formulations for treatment of hypotension in the setting of anesthesia; pharmaceutical formulations containing ephedrine for treatment of clinically important hypotension in the setting of anesthesia; pharmaceutical formulations for treatment of hypotension

Filing History

WITHDRAWAL OF ATTORNEY GRANTED
Jun 4, 2024 WOAG
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Jun 4, 2024 WOAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 2, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
May 2, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 31, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 30, 2023 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 15, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 15, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 15, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 29, 2022 GNRN
NON-FINAL ACTION E-MAILED
Sep 29, 2022 GNRT
SU - NON-FINAL ACTION - WRITTEN
Sep 29, 2022 CNRT
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 7, 2022 ASGN
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 3, 2022 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Sep 2, 2022 SUPC
SOU EXTENSION 3 GRANTED
Sep 2, 2022 EX3G
ITU LETTER MAILED, NO RESPONSE REQUIRED
Sep 2, 2022 IULN
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 13, 2022 AITU
SOU TEAS EXTENSION RECEIVED
Jul 12, 2022 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 12, 2022 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jul 12, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 12, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 12, 2022 REAP
SOU EXTENSION 3 FILED
Jul 11, 2022 EXT3
USE AMENDMENT FILED
Jul 11, 2022 IUAF
SOU TEAS EXTENSION RECEIVED
Jul 11, 2022 EEXT
TEAS STATEMENT OF USE RECEIVED
Jul 11, 2022 EISU
ASSIGNED TO EXAMINER
Mar 7, 2022 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 13, 2022 EXRA
SOU EXTENSION 2 GRANTED
Jan 11, 2022 EX2G
SOU EXTENSION 2 FILED
Jan 11, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 11, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 26, 2021 EXRA
SOU EXTENSION 1 GRANTED
Jun 24, 2021 EX1G
SOU EXTENSION 1 FILED
Jun 24, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 24, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 12, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 17, 2020 NPUB
PUBLISHED FOR OPPOSITION
Nov 17, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 28, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 5, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 2, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 2, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 2, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 2, 2020 CNEA
ASSIGNED TO EXAMINER
Oct 2, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 14, 2020 NWOS
NEW APPLICATION ENTERED
Jul 22, 2020 NWAP

Related Trademarks

More from this Owner

ETON

ETON

ETON PHARMACEUTICALS logo

ETON PHARMACEUTICALS

DESMODA logo

DESMODA

DESMODA logo

DESMODA

GALZIN logo

GALZIN

KHINDIVI logo

KHINDIVI